Search research articles
Contact Us
Filters
Showing results (41-50 of 136) with videos related to
Page
of 14
Sort By:
Clinical Pharmacokinetics
|
May 11, 2011
Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on 4-anilinoquinazolines
Matthias Scheffler, Paola Di Gion, Oxana Doroshyenko, et al.
Annual Review of Pharmacology and Toxicology
|
August 30, 2018
Assessment of Pharmacokinetic Drug-Drug Interactions in Humans: In Vivo Probe Substrates for Drug Metabolism and Drug Transport Revisited
Uwe Fuhr, Chih-Hsuan Hsin, Xia Li, et al.
Biochemical Pharmacology
|
June 5, 2003
An amperometric biosensor with human CYP3A4 as a novel drug screening tool
Shiba Joseph, James F Rusling, Yuri M Lvov, et al.
European Journal of Endocrinology
|
March 25, 2010
Bioequivalence between novel ready-to-use liquid formulations of the recombinant human GH Omnitrope and the original lyophilized formulations for reconstitution of Omnitrope and Genotropin
Uwe Fuhr, Daniel Tuculanu, Alexander Berghout, et al.
European Journal of Clinical Pharmacology
|
September 9, 2011
Natriuretic peptides in therapy for decompensated heart failure
Natig Gassanov, Esther Biesenbach, Evren Caglayan, et al.
Antimicrobial Agents and Chemotherapy
|
August 9, 2017
Pharmacokinetics of Intravenous Finafloxacin in Healthy Volunteers
Max Taubert, Joseph Chiesa, Mark Lückermann, et al.
Pharmacology & Toxicology
|
June 20, 2002
Cytochrome P450 enzymes contributing to demethylation of maprotiline in man
Lars Brachtendorf, Alexander Jetter, K Tobias Beckurts, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
July 24, 2019
A HILIC-MS/MS assay for the quantification of metformin and sitagliptin in human plasma and urine: A tool for studying drug transporter perturbation
Oliver Scherf-Clavel, Martina Kinzig, Marc S Stoffel, et al.
Clinical Pharmacology and Therapeutics
|
June 12, 2023
Physiologically Based Pharmacokinetic Modeling of Bergamottin and 6,7-Dihydroxybergamottin to Describe CYP3A4 Mediated Grapefruit-Drug Interactions
Laura Maria Fuhr, Fatima Zahra Marok, Uwe Fuhr, et al.
Journal of Pharmacological and Toxicological Methods
|
November 4, 2015
Development and validation of an in vitro, seven-in-one human cytochrome P450 assay for evaluation of both direct and time-dependent inhibition
Dominik Dahlinger, Sabrina Duechting, Daniela Nuecken, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 136) with videos related to
Sort By:
Page
of 14
Clinical Pharmacokinetics
|
May 11, 2011
Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on 4-anilinoquinazolines
Matthias Scheffler, Paola Di Gion, Oxana Doroshyenko, et al.
Annual Review of Pharmacology and Toxicology
|
August 30, 2018
Assessment of Pharmacokinetic Drug-Drug Interactions in Humans: In Vivo Probe Substrates for Drug Metabolism and Drug Transport Revisited
Uwe Fuhr, Chih-Hsuan Hsin, Xia Li, et al.
Biochemical Pharmacology
|
June 5, 2003
An amperometric biosensor with human CYP3A4 as a novel drug screening tool
Shiba Joseph, James F Rusling, Yuri M Lvov, et al.
European Journal of Endocrinology
|
March 25, 2010
Bioequivalence between novel ready-to-use liquid formulations of the recombinant human GH Omnitrope and the original lyophilized formulations for reconstitution of Omnitrope and Genotropin
Uwe Fuhr, Daniel Tuculanu, Alexander Berghout, et al.
European Journal of Clinical Pharmacology
|
September 9, 2011
Natriuretic peptides in therapy for decompensated heart failure
Natig Gassanov, Esther Biesenbach, Evren Caglayan, et al.
Antimicrobial Agents and Chemotherapy
|
August 9, 2017
Pharmacokinetics of Intravenous Finafloxacin in Healthy Volunteers
Max Taubert, Joseph Chiesa, Mark Lückermann, et al.
Pharmacology & Toxicology
|
June 20, 2002
Cytochrome P450 enzymes contributing to demethylation of maprotiline in man
Lars Brachtendorf, Alexander Jetter, K Tobias Beckurts, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
July 24, 2019
A HILIC-MS/MS assay for the quantification of metformin and sitagliptin in human plasma and urine: A tool for studying drug transporter perturbation
Oliver Scherf-Clavel, Martina Kinzig, Marc S Stoffel, et al.
Clinical Pharmacology and Therapeutics
|
June 12, 2023
Physiologically Based Pharmacokinetic Modeling of Bergamottin and 6,7-Dihydroxybergamottin to Describe CYP3A4 Mediated Grapefruit-Drug Interactions
Laura Maria Fuhr, Fatima Zahra Marok, Uwe Fuhr, et al.
Journal of Pharmacological and Toxicological Methods
|
November 4, 2015
Development and validation of an in vitro, seven-in-one human cytochrome P450 assay for evaluation of both direct and time-dependent inhibition
Dominik Dahlinger, Sabrina Duechting, Daniela Nuecken, et al.
Page
of 14